The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Renal Mass and Localized Renal Cancer: AUA Guideline
Open accessAbstract
PURPOSE: This AUA Guideline focuses on evaluation/counseling and management of adult patients with clinically localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions. MATERIALS AND METHODS: Systematic review utilized research from the Agency for Healthcare Research and Quality and additional supplementation by the authors and consultant methodologists. Evidence-based statements were based on body of evidence strength Grade A/B/C (Strong/Moderate/Conditional Recommendations, respectively) with additional statements presented as Clinical Principles or Expert Opinions. RESULTS: Great progress has been made since the previous guidelines on management of localized renal masses were released (2009). The current guidelines provide updated, evidence-based recommendations regarding evaluation/counseling of patients with clinically localized renal masses, including the evolving role of renal mass biopsy. Given great variability of clinical, oncologic and functional characteristics, index patients are not utilized and the panel advocates individualized counseling/management. Management options (partial nephrectomy/radical nephrectomy/thermal ablation/active surveillance) are reviewed including recent data about comparative effectiveness and potential morbidities. Oncologic issues are prioritized while recognizing that functional outcomes are of great importance for survivorship for most patients with localized kidney cancer. A more restricted role for radical nephrectomy is recommended following well-defined selection criteria. Priority for partial nephrectomy is recommended for clinical T1a lesions, along with selective use of thermal ablation, particularly for tumors ≤3.0 cm. Important considerations for shared decision-making about active surveillance are explicitly defined. CONCLUSIONS: Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Guideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Self-citationHuang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V., Scardino, P. T., & Russo, P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70803-8 · Cited by 1,613
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size
FRANK, I., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2003) · Journal of Urology · doi:10.1097/01.ju.0000095475.12515.5e · Cited by 1,080
Poppel, H. V., Pozzo, L. D., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., Colombel, M. C., Klotz, L. H., Skinner, E. C., Keane, T. E., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.12.013 · Cited by 1,048
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
Srigley, J. R., Delahunt, B., Eble, J. N., Egevad, L., Epstein, J. I., Grignon, D., Hes, O., Moch, H., Montironi, R., Tickoo, S. K., et al. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318299f2d1 · Cited by 1,047
Poppel, H. V., Pozzo, L. D., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., Maréchal, J.-M., Klotz, L. H., Skinner, E. C., Keane, T. E., et al. (2006) · European Urology · doi:10.1016/j.eururo.2006.11.013 · Cited by 1,040
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Znaor, A., Lortet-Tieulent, J., Laversanne, M., Jemal, A., & Bray, F. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.002 · Cited by 984
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Davis, C. F., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 842
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy
Marconi, L., Dabestani, S., Lam, T. B., Hofmann, F., Stewart, F., Norrie, J., Bex, A., Bensalah, K., Canfield, S. E., Hora, M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.07.072 · Cited by 601
Gervais, D. A., McGovern, F. J., Arellano, R. S., McDougal, W. S., & Mueller, P. R. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.185.1.01850064 · Cited by 587
Self-citationExcise, Ablate or Observe: The Small Renal Mass Dilemma—A Meta-Analysis and Review
Kunkle, D. A., Egleston, B. L., & Uzzo, R. G. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.11.047 · Cited by 517
Self-citationActive surveillance of small renal masses: progression patterns of early stage kidney cancer.
Jewett, M., Mattar, K., Basiuk, J., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.030 · Cited by 473
Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD
Hallan, S. I., Ritz, E., Lydersen, S., Romundstad, S., Kvenild, K., & Orth, S. R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070730 · Cited by 439
Blom, J. H. M., van Poppel, H., Maréchal, J., Didier Jacqmin, D., Schröder, F. H., de Prijck, L., & Sylvester, R. J. (2008) · European Urology · doi:10.1016/j.eururo.2008.09.052 · Cited by 436
Patel, H. D., Johnson, M. H., Pierorazio, P. M., Sozio, S. M., Sharma, R., Iyoha, E., Bass, E. B., & Allaf, M. E. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.11.029 · Cited by 364
Self-citationDecline in Renal Function after Partial Nephrectomy: Etiology and Prevention
Mir, M. C., Ercole, C., Takagi, T., Zhang, Z., Velet, L., Remer, E. M., Demirjian, S., & Campbell, S. C. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.01.093 · Cited by 322
Self-citationYoung, J. R., Margolis, D., Sauk, S., Pantuck, A. J., Sayre, J., & Raman, S. S. (2013) · Radiology · doi:10.1148/radiol.13112617 · Cited by 309
Lane, B. R., Campbell, S. C., Demirjian, S., & Fergany, A. F. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.121 · Cited by 249
Self-citationGenetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
Linehan, W. M. (2012) · Genome Research · doi:10.1101/gr.131110.111 · Cited by 243
Lane, B. R., Demirjian, S., Derweesh, I. H., Takagi, T., Zhang, Z., Velet, L., Ercole, C. E., Fergany, A. F., & Campbell, S. C. (2015) · European Urology · doi:10.1016/j.eururo.2015.04.043 · Cited by 213
Self-citationUser-centered design and the development of patient decision aids: protocol for a systematic review
Witteman, H. O., Dansokho, S. C., Colquhoun, H., Coulter, A., Dugas, M., Fagerlin, A., Giguere, A. M., Glouberman, S., Haslett, L., Hoffman, A., et al. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-11 · Cited by 202
Robotic versus Open Partial Nephrectomy: A Systematic Review and Meta-Analysis
Wu, Z., Li, M., Liu, B., Cai, C., Ye, H., Lv, C., Yang, Q., Sheng, J., Song, S., Qu, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094878 · Cited by 159
Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model
Kutikov, A., Egleston, B. L., Canter, D. J., Smaldone, M. C., Wong, Y., & Uzzo, R. G. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.07.100 · Cited by 126
Self-citationGuðbjartsson, T., Jónasdóttir, T. J., Thoroddsen, Á., Einarsson, G., Jonsdottir, G. M., Kristjánsson, K., Harðarson, S., Magnússon, K. G., Gulcher, J. R., Stefánsson, K., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10513 · Cited by 96
Laparoscopic Cryoablation of Renal Masses: Single-center Long-term Experience
Tanagho, Y. S., Roytman, T. M., Bhayani, S. B., Kim, E. H., Benway, B. M., Gardner, M. W., & Figenshau, R. S. (2012) · Urology · doi:10.1016/j.urology.2012.03.044 · Cited by 53
Circulating Tumor Cell Composition in Renal Cell Carcinoma
Nel, I., Gauler, T. C., Bublitz, K., Lazaridis, L., Görgens, A., Giebel, B., Schüler, M., & Hoffmann, A.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153018 · Cited by 45
Cited by
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
Campbell, S. C., Clark, P. E., Chang, S. S., Karam, J. A., Souter, L., & Uzzo, R. G. (2021) · Journal of Urology · doi:10.1097/ju.0000000000001911 · Cited by 775
Self-citationHeller, N., Isensee, F., Maier-Hein, K. H., Hou, X., Xie, C., Li, F., Nan, Y., Mu, G., Lin, Z., Han, M., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101821 · Cited by 579
Metadata
- Authors
- Campbell, S., Uzzo, R. G., Allaf, M. E., Bass, E. B., Cadeddu, J. A., Chang, A., Clark, P. E., Davis, B. J., Derweesh, I. H., Giambarresi, L., Gervais, D. A., Hu, S. L., Lane, B. R., Leibovich, B. C., & Pierorazio, P. M.
- Venue
- Journal of Urology
- Published
- 2017-09
- Volume
- 198
- Issue
- 3
- Pages
- 520-529
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2610758168
- Cited by
- 1,242
- References
- 29
- FWCI
- 115.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.